Generis and Userlane forge strategic partnership
Generis and Userlane forge strategic partnership to accelerate digital transformation in regulated industries
19 December 2023 – London, UK, Munich, Germany: Generis and Userlane today announced a strategic partnership.
Generis is the developer of the CARA platform for data, content, and business process management in regulated industries, and Userlane is a Munich-based tech company known for its Digital Adoption Platform (DAP) designed for enterprises. This collaboration aims to integrate their systems, enabling customers of the CARA Platform to expedite user adoption and rapidly achieve higher returns on investment.
The CARA Platform empowers to streamline complex regulated business processes, data, and content on a single platform. It facilitates the instant creation, localization, and reuse of information, thus accelerating work and ensuring accuracy across organizational processes.
Userlane’s Digital Adoption Platform is designed to maximize the value of software investments. When working with the CARA Platform, it offers tailored process guides, on-demand support, and efficient onboarding and training processes. Moreover, Userlane’s platform enables enterprise customers to track and analyze software adoption within their organizations.
This partnership between Generis and Userlane lets companies use the best of both technologies. One platform supports business processes, ensuring compliance across various business areas, and supports efficient quality functions. As a result, it speeds up digital transformation and software implementation for Generis’ customers. Integrating Userlane into the CARA platform brings significant benefits, including:
- Quicker deployment and training on the CARA Platform
- Increased user satisfaction
- Enhanced customer communication
- Greater adoption of new features and updates on the CARA Platform
This collaboration marks a significant step towards accelerating digital transformation in regulated industries, ensuring that companies can fully leverage their technological investments.
Generis is a UK-headquartered developer of world-class data, content and business process management for regulated industries globally. 60% of the top 20 life sciences companies rely on Generis’ flagship CARA™ Life Sciences Platform, including AbbVie, UCB, Biogen, Reckitt, Bristol Myers Squibb, Bayer, Pfizer, and Merck KGaA. Today Generis serves more than 750,000 users worldwide, across use cases ranging from RIM, Regulatory / R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information / Medical Affairs applications and more. More at generiscorp.com.